Belgium· BE-AMP-SAM326821-00

Piperacilline-Tazobactam EG 4 g - 0.5 g

A piperacillin und beta-lactamase-inhibitor product containing piperacillin sodium, registered in Belgium by EG. The same ATC class is registered in 12 of our 19 countries.

ATC J01CR05

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about piperacillin sodiumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Piperacillin und beta-lactamase-inhibitor is registered in 12 of 19 countries.

Countries holding a registration under ATC J01CR05 (piperacillin und beta-lactamase-inhibitor), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search piperacillin und beta-lactamase-inhibitor products by name

Piperacillin und beta-lactamase-inhibitor · ATC J01CR05

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of piperacillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (14 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Piperacillin und beta-lactamase-inhibitor · price per daily dose (14 g)

USD · FX 28 Sept 2026

CH Switzerland$158.68

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Piperacillin Sodium
Manufacturer: EG
Country: Belgium (BE)
ATC code: J01CR05
ATC class: Piperacillin und Beta-Lactamase-Inhibitor
Defined daily dose: 14 g, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

be_apb
0792655
be_apb
2572733
be_apb
3796216

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

111 interactions on record for piperacillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check piperacillin und beta-lactamase-inhibitor against other medicines How interaction checks work

Piperacillin und beta-lactamase-inhibitor · interactions on record

111 records

5 severe
22 moderate
4 minor
80 info

Most severe, free to view

VancomycinA07AA09severe
VancomycinJ01XA01severe
MethotrexateL01BA01severe
MethotrexateL04AX03severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Piperacillin und beta-lactamase-inhibitor in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piperacillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

France · Piperacilline Panpharma
Italy · Piperacillina K24 Pharmaceuticals, Piperital

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e7f6f8ff-59a3-4cd1-9915-ecdb79995391
GET /v1/drugs/e7f6f8ff-59a3-4cd1-9915-ecdb79995391?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Piperacilline-Tazobactam EG 4 g - 0.5 g",
  "name_fr": "Piperacilline-Tazobactam EG 4 g - 0.5 g",
  "name_nl": "Piperacilline-Tazobactam EG 4 g - 0.5 g",
  "amp_code": "SAM326821-00",
  "strengths": [
    "4170.0000",
    "4170.0000",
    "4000.0000",
    "4000.0000",
    "536.6000",
    "536.6000",
    "500.0000",
    "500.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Piperacillin Sodium",
    "Piperacillin",
    "Tazobactam Sodium",
    "Tazobactam"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Piperacillin and Beta-Lactamase Inhibitor",
  "authorisation_numbers": [
    "BE326821"
  ]
}

API reference MCP server Plans

See everything about piperacillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console